In accordance with the decree of the State Committee for Healthcare of the People's Republic of China, the work on preventive vaccination of the population was fully restored in Beijing, vaccine manufacturers resumed production.
In January, a vaccine was developed that was tested on animals. In the course of work, the experience of creating a vaccine against the Ebola virus was taken into account.
According to www.enovosty.com, a human trial began in the second half of March. Project participants were infected with the virus during vaccination. Antibodies were administered to them, after which control was established over the volunteers, the task of which was to determine whether these people had acquired immunity to the virus.
Three groups were created for the tests, each of which will consist of 36 people aged 18 to 60 years old, all from Wuhan. They are quarantined for two weeks, and then for six months, doctors plan to watch how their body reacts to serum.